Announcement PDF Appendix 3H - Notification of cessation of securities Announcement Summary Entity name NEUREN PHARMACEUTICALS LIMITED Announcement Type New announcement Date of this announcement Thursday April 03, 2025 Details of +securities that have ceased ASX +security code Security description NEU ORDINARY FULLY PAID Number of +securities that have ceased 1,269,250 The +securities have ceased due to Date of cessation Cancellation pursuant to an on-market buy-back 31/03/2025 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities 1/4 Appendix 3H - Notification of cessation of securities Part 1 - Announcement Details 1.1 Name of +Entity NEUREN PHARMACEUTICALS LIMITED We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type Registration Number ABN 72111496130 1.3 ASX issuer code NEU 1.4 The announcement is New announcement 1.5 Date of this announcement 3/4/2025 Appendix 3H - Notification of cessation of securities 2/4 Appendix 3H - Notification of cessation of securities Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description NEU : ORDINARY FULLY PAID Quoted +equity securities or +debt securities that have ceased Number of securities that have ceased 1,269,250 Reason for cessation Cancellation pursuant to an on-market buy-back Date of cessation 31/3/2025 Is the entity paying any consideration for the cessation? Yes In what currency is the consideration being paid? AUD - Australian Dollar Total consideration paid or payable for the securities AUD 15,341,672.730000000000 Any other information the entity wishes to notify to ASX about the cessation? Shares bought back under the buy-back up to 31 March 2025. Appendix 3H - Notification of cessation of securities 3/4 Appendix 3H - Notification of cessation of securities Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description NEU : ORDINARY FULLY PAID Total number of +securities on issue 126,043,374 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description NEUAZ : ORDINARY FULLY PAID Total number of +securities on issue 1,950,000 NEUAAB : OPTION EXPIRING 08-JUL-2026 EX $3.83 450,000 NEUAAA : OPTIONS EXPIRING 03-FEB-2026 EX $3.46 650,000 NEUAAC : OPTION EXPIRING 07-FEB-2029 EX $23.09 260,000 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form. Appendix 3H - Notification of cessation of securities 4/4